Nowadays, histopathological samples do not only serve pathological diagnostics, but are also subjects of biomarker tests for prognosis and prediction of drug effects. Based on a recently published guide line, we review the practice of pathological biomarkers assessment of colorectal tumours. In view of its importance, particular attention is paid to the aspects of microsatellite instability.